Roche presents pivotal data demonstrating Tecentriq in combination with Avastin improves overall survival in people with the most common form of liver cancer

Ads

You May Also Like

MDxHealth Opens New Service and Research Laboratory in The Netherlands

COMPANY ANNOUNCEMENT                                                                  HERSTAL, BELGIUM - 07:00 CEST, October 5, 2017 - MDxHealth ...